Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials
Xia-Hong You,
Yu-Huan Jiang,
Zhou Fang,
Yao Li,
Zi-Jin Xia,
Xiao-Zhong Wang,
Hou-Qun Ying
Affiliations
Xia-Hong You
Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Yu-Huan Jiang
Department of Clinical Laboratory, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Zhou Fang
Department of Laboratory Medicine, Nanchang University Medical College, Nanchang, Jiangxi, China
Yao Li
Department of Laboratory Medicine, Nanchang University Medical College, Nanchang, Jiangxi, China
Zi-Jin Xia
Department of Laboratory Medicine, Nanchang University Medical College, Nanchang, Jiangxi, China
Xiao-Zhong Wang
Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Hou-Qun Ying
Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
